Immunome director Isaac Barchas reports disposal of common shares worth $2.18 million
IMNM•Barchas reports share sales in August
- Immunome director Isaac Barchas reported selling 83,464 common shares across Aug. 10-12, 2026.
- Sales included 72,416 shares held indirectly, sold at weighted average prices of USD 26.07 and USD 26.23.
- Barchas also sold 11,048 shares directly at USD 27.25.
- Directly held stake rose to 92,211 shares following the Aug. 12 sale.
- Indirect holdings fell to zero following the Aug. 11 sale.
